Lebenswissenschaften
Refine
Year of publication
Document Type
- Article (141)
- conference proceeding (presentation, abstract) (11)
- Part of a Book (5)
- Book (3)
- Working Paper (3)
- Other (2)
- Research Data (2)
- conference talk (1)
- Doctoral Thesis (1)
- Report (1)
Is part of the Bibliography
- no (170)
Keywords
- REPLACEMENT (20)
- Total hip arthroplasty (16)
- SURGERY (13)
- Total knee arthroplasty (13)
- ARTHROPLASTY (12)
- Frailty (11)
- HIP (10)
- MANAGEMENT (10)
- OUTCOMES (10)
- Physiotherapie (9)
Institute
- Fakultät Maschinenbau (137)
- Forschungsstelle für Orthopädie und Ergonomie (133)
- Fakultät Sozial- und Gesundheitswissenschaften (25)
- Research Center of Health Sciences and Technology - RCHST (24)
- Research Center for Artificial Intelligence - RCAI (9)
- Fakultät Informatik und Mathematik (7)
- Research Center of Biomedical Engineering - RCBE (7)
- Fakultät Business and Management (4)
- Fakultät Angewandte Natur- und Kulturwissenschaften (2)
- Labor Physiotherapie (LPh) (2)
Begutachtungsstatus
- peer-reviewed (149)
- begutachtet (2)
BACKGROUND
Autologous fat grafting is widely used in reconstructive, aesthetic and regenerative surgery and often requires repeated applications. Cryopreservation of lipoaspirate enables autologous fat banking and off-the-shelf availability; however, its clinical implementation is limited by freezing-induced tissue injury, regulatory requirements and uncertainties regarding the optimal preservation protocol. Glycerol is a biocompatible cryoprotective agent with promising preliminary data. Nevertheless, the optimal concentration for lipoaspirate cryopreservation remains unknown. The aim of this study was to determine the optimal glycerol concentration for preservation of adipose tissue processed according to the Cell-Enriched Lipotransfer (CELT) protocol in clinically relevant volumes under GMP-compatible conditions.
METHODS
Lipoaspirates from 10 patients were processed by centrifugation according to the CELT protocol and allocated into experimental groups: fresh unfrozen control, frozen samples without cryoprotectant, frozen samples with PBS, and frozen samples supplemented with glycerol in concentrations ranging from 10% to 60%. Samples were cryopreserved using a controlled freezing rate at a temperature of -80 °C for 24 h. Large-volume cryopreservation was additionally performed with the best concentration of glycerol. Post-thaw tissue quality was assessed by resazurin assay of whole tissue, stromal vascular fraction (SVF) cell live/dead counting, and resazurin assay after short-term cell culture.
RESULTS
Glycerol supplementation improved post-thaw tissue viability compared with cryopreservation without cryoprotectant or with PBS alone. An optimal concentration range between 10% and 30% glycerol was identified, with highest preservation of metabolic activity and surviving cell yield observed at 20%. Higher glycerol concentrations resulted in a marked decline in tissue quality. Cryopreservation in large volume was feasible and did not impair post-thaw viability compared with small-volume samples.
CONCLUSIONS
Glycerol-based cryopreservation allows effective and GMP-compatible preservation of human lipoaspirate. An optimal glycerol concentration range was identified, enabling large-volume fat banking without compromising tissue quality. This protocol provides a clinically applicable strategy for autologous fat storage and may facilitate repeated reconstructive and regenerative treatments.
OBJECTIVE
Since the first use of silicone implants by Cronin in 1962, there have been several attempts to introduce alternative filling materials for breast implants on the market. A promising new development are lightweight implants, whose filler material is one third lighter than conventional silicone gel. While these implants have been used primarily for aesthetic augmentation, a benefit could be expected particularly in post-mastectomy reconstruction.
MATERIALS AND METHODS
Since 2019, 92 operations using lightweight implants have been performed at our clinic, 61 of them for breast reconstruction after mastectomy. These have been compared to 92 breast reconstructions using conventional silicone implants.
RESULTS
The average volume of the lightweight implants was 30% higher than of the conventional implants (452 ml resp. 347 ml), whereas the implant weight was comparable in both groups (317 g resp. 347 g). Grade 3-4 capsular fibrosis was seen in 6 cases in both groups; revision was required 9 times (lightweight implants) and 7 times (conventional silicone implants) during the follow-up period.
DISCUSSION
To our knowledge, this is the first study to investigate the use of lightweight implants in breast reconstruction. With exception of the filler material, the implants used in the two groups were comparable in shape and surface. The inserted lightweight implants had a greater volume but nearly the same weight as the conventional implants and were used in patients with a higher body mass index. Thus, lightweight implants were preferred in patients whose reconstruction required a larger implant volume.
CONCLUSION
Lightweight implants are a new alternative for breast reconstruction especially in case that larger implant volume is demanded. The increased complication rate has to be verified in further studies.
Manual processing of lipoaspirate can enhance stem cell concentration, thereby improving the take rate, which still represents a major challenge in autologous fat transfer. However, since the preparation consists of many manual steps that are difficult to standardize, we investigated the influence of residual tumescent solution on the macroscopic and microscopic outcome of the mechanically processed lipoaspirate. Additionally, we investigated whether sedimentation followed by vacuum filtration of the aqueous phase could accelerate processing by replacing the initial centrifugation step. Samples with more than 5% remaining aqueous phase show no clearly defined oil phase, preventing any volume reduction. In contrast, all centrifuged samples produced a clear oil phase. The remaining tissue, as confirmed by both histology and viability assays, was superior to nanofat. Although sedimentation and filtration in the LipoCollector did not sufficiently separate enough aqueous phase from the lipoaspirate, tissue viability was significantly higher compared to our control container. Our findings indicate that centrifugation remains essential for effective aqueous phase separation and further mechanical processing, while the automatic filtration may enhance processing efficiency. These results indicate that further work is needed to simplify mechanical processing, as the outcome can be significantly influenced by parameters such as tumescent impurities.
Diese Ausgabe des Versorgungs-Reports widmet sich schwerpunktmäßig der Bedeutung von medizinischen Leitlinien in der Gesundheitsversorgung. Leitlinien geben den Behandelnden diagnostische und therapeutische Empfehlungen an die Hand. Sie werden nach systematischen und evidenzbasierten Kriterien entwickelt und zielen darauf ab, die Versorgungsqualität für Patientinnen und Patienten zu verbessern. Als Patientenleitlinien nehmen sie Einfluss auf die Gesundheitskompetenz der Bevölkerung. Ihre Umsetzung im Versorgungsalltag ist herausfordernd.
Die Expertenbeiträge im Versorgungs-Report setzen sich umfassend mit der Praxis von Leitlinien auseinander. Sie beschreiben Methodik und Verfahren zur Erstellung vertrauenswürdiger Leitlinien sowie zu ihrer Evaluation. Sie berichten über die Ergebnisse empirischer Untersuchungen zur Umsetzung von Leitlinienempfehlungen in der realen Versorgung und stellen praxisorientiert Versorgungsstrukturen und konkrete Vertragsmodelle zur Förderung der Leitlinienanwendung vor.
Der Teil „Daten und Analysen“ berichtet auf Basis von AOK-Abrechnungsdaten über die Häufi gkeit von Erkrankungen und Behandlungen in Deutschland und nimmt dabei die Auswirkungen der Pandemie in den Blick. Weitere Daten zu Behandlungshäufigkeiten von mehr als 1.500 Krankheiten stehen unter www.mwv-open.de zur Verfügung.
BACKGROUND
The COVID-19 pandemic saw a steep increase in the number of rapidly published scientific studies, especially early in the pandemic. Some have suggested COVID-19 trial reporting is of lower quality than typical reports, but there is limited evidence for this in terms of primary outcome reporting. The objective of this study was to assess the prevalence of completely defined primary outcomes reported in registry entries, preprints, and journal articles, and to assess consistent primary outcome reporting between these sources.
METHODS
This is a descriptive study of a cohort of registered interventional clinical trials for the treatment and prevention of COVID-19, drawn from the DIssemination of REgistered COVID-19 Clinical Trials (DIRECCT) study dataset. The main outcomes are: 1) Prevalence of complete primary outcome reporting; 2) Prevalence of consistent primary outcome reporting between registry entry and preprint as well as registry entry and journal article pairs.
RESULTS
We analyzed 87 trials with 116 corresponding publications (87 registry entries, 53 preprints and 63 journal articles). All primary outcomes were completely defined in 47/87 (54%) registry entries, 31/53 (58%) preprints and 44/63 (70%) journal articles. All primary outcomes were consistently reported in 13/53 (25%) registry-preprint pairs and 27/63 (43%) registry-journal article pairs. No primary outcome was specified in 13/53 (25%) preprints and 8/63 (13%) journal articles. In this sample, complete primary outcome reporting occurred more frequently in trials with vs. without involvement of pharmaceutical companies (76% vs. 45%), and in RCTs vs. other study designs (68% vs. 49%). The same pattern was observed for consistent primary outcome reporting (with vs. without pharma: 56% vs. 12%, RCT vs. other: 43% vs. 22%).
CONCLUSIONS
In COVID-19 trials in the early phase of the pandemic, all primary outcomes were completely defined in 54%, 58%, and 70% of registry entries, preprints and journal articles, respectively. Only 25% of preprints and 43% of journal articles reported primary outcomes consistent with registry entries.
Gesundheitskompetenz (GK), als Fähigkeit Gesundheitsinformationen zu beziehen, diese verstehen, bewerten und anwenden zu können, hat entscheidenden Einfluss auf Gesundheitschancen und -ergebnisse von Individuen. Dieses Kapitel beschäftigt sich damit, wie Gesundheitsfachkräfte die GK ihrer Patient*innen berücksichtigen und fördern können. GK-orientierte Versorgung wird vorgestellt als Kernelement einer organisationalen GK, durch die Einrichtungen und Personen im Gesundheitssystem die Patient*innen unterstützen, sich besser zurecht zu finden und informierte Entscheidungen in Bezug auf ihre Gesundheit zu fällen. Im Anschluss werden zentrale Herausforderungen und wirksame Maßnahmen für eine Umsetzung von GK-orientierter Versorgung durch Gesundheitsfachkräfte beschrieben, wie z. B. Strategien zur professionellen Einschätzung der GK von Patient*innen und Potenziale einer gezielten Ausbildung der Fachkräfte zu GK-orientierten Beratungstechniken.